Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
EDGE Therapeutics

EDGE Therapeutics

Founded in 2009, EDGE Therapeutics is a biotechnology company that raised an IPO in 2015, and was subsequently merged into PDS Biotechnology (NASDAQ: PDSB), a clinical stage biopharmaceutical company with a growing pipeline of cancer immunotherapies and infectious disease vaccines.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

June 4, 2013
EDGE Therapeutics raises a $18,000,000 series C round.

Funding rounds

Patents

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link
Golden logo
By using this site, you agree to our Terms & Conditions.